Bioregulator

Bioregulators are short peptides — typically two to five amino acids — that occur naturally in specific organs and tissues and are thought to regulate those tissues' function. The concept comes from Russian peptide research, developed primarily by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology from the 1970s onward. The theory: each organ produces characteristic short peptides that regulate gene expression in that tissue. Extract them, synthesise them, and administer them — and you may be able to restore declining tissue function associated with aging. Epithalon (from the pineal gland), Thymosin Alpha-1 (from thymic tissue), and several other compounds fit this framework. The research tradition behind bioregulators is extensive in Russian-language literature; the international replication of that work is much thinner. The concept is scientifically plausible at the molecular level. The clinical translation — that administering a synthetic version of an organ-specific peptide restores function in aging humans — requires evidence that mostly hasn't been produced in Western peer-reviewed formats. The framework is useful context for understanding where Epithalon comes from and why it's positioned as it is. It's not a validation of the clinical claims.